Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Y-90-DOTATOC |
Synonyms | |
Therapy Description |
Y-90-DOTATOC is a radioconjugate comprising the somatostatin analogue octreotide linked to the radionuclide Yttrium-90, which potentially induces antitumor activity (PMID: 23492685, PMID: 11994522). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Y-90-DOTATOC | Y-90 DOTATOC|(90)Y-DOTATOC|90Y-DOTATOC | Y-90-DOTATOC is a radioconjugate comprising the somatostatin analogue octreotide linked to the radionuclide Yttrium-90, which potentially induces antitumor activity (PMID: 23492685, PMID: 11994522). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05568017 | Phase II | Y-90-DOTATOC | Neoadjuvant PRRT With Y-90-DOTATOC in pNET | Unknown status | ITA | 0 |